Literature DB >> 12537219

Outcomes after esophagectomy: a ten-year prospective cohort.

Stephen H Bailey1, David A Bull, David H Harpole, Jeffrey J Rentz, Leigh A Neumayer, Theodore N Pappas, Jennifer Daley, William G Henderson, Barbara Krasnicka, Shukri F Khuri.   

Abstract

BACKGROUND: The Department of Veterans Affairs National Surgical Quality Improvement Program is a unique resource to prospectively analyze surgical outcomes from a cross-section of surgical services nationally. We used this database to assess risk factors for morbidity and mortality after esophagectomy in Veterans Affairs Medical Centers from 1991 to 2001.
METHODS: A total of 1,777 patients underwent an esophagectomy at 109 Veterans Affairs hospitals with complete in-hospital and 30-day outcomes recorded. Bivariate and multivariable analyses were completed.
RESULTS: Thirty-day mortality was 9.8% (174/1,777) and the incidence of one or more of 20 predefined complications was 49.5% (880/1,777). The most frequent postoperative complications were pneumonia in 21% (380/1,777), respiratory failure in 16% (288/1,777), and ventilator support more than 48 hours in 22% (387/1,777). Preoperative predictors of mortality based on multivariable analysis included neoadjuvant therapy, blood urea nitrogen level of more than 40 mg/dL, alkaline phosphatase level of more than 125 U/L, diabetes mellitus, alcohol abuse, decreased functional status, ascites, and increasing age. Preoperative factors impacting morbidity were increasing age, dyspnea, diabetes mellitus, chronic obstructive pulmonary disease, alkaline phosphatase level of more than 125 U/L, lower serum albumin concentration, increased complexity score, and decreased functional status. Intraoperative risk factors for mortality included the need for transfusion; intraoperative risk factors for morbidity included the need for transfusion and longer operative time.
CONCLUSIONS: These data constitute the largest prospective outcomes cohort in the literature and document a near 50% morbidity rate and 10% mortality rate after esophagectomy. Data from this study can be used to better stratify patients before esophagectomy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12537219     DOI: 10.1016/s0003-4975(02)04368-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  127 in total

1.  A pilot study of the technical and oncologic feasibility of thoracoscopic esophagectomy with extended lymph node dissection in the prone position for clinical stage I thoracic esophageal carcinoma.

Authors:  Hiroyuki Daiko; Mitsuyo Nishimura
Journal:  Surg Endosc       Date:  2011-09-23       Impact factor: 4.584

Review 2.  Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how?

Authors:  Vani J A Konda; Mark K Ferguson
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

3.  Nationwide analysis of short-term surgical outcomes of minimally invasive esophagectomy for malignancy.

Authors:  Pragatheeshwar Thirunavukarasu; Emmanuel Gabriel; Kristopher Attwood; Moshim Kukar; Steven N Hochwald; Steven J Nurkin
Journal:  Int J Surg       Date:  2015-11-18       Impact factor: 6.071

Review 4.  Endoscopic options for treatment of dysplasia in Barrett's esophagus.

Authors:  R Brooks Vance; Kerry B Dunbar
Journal:  World J Gastrointest Endosc       Date:  2015-12-25

5.  External validation of the Ferguson pulmonary risk score for predicting major pulmonary complications after oesophagectomy†.

Authors:  J Matthew Reinersman; Mark S Allen; Claude Deschamps; Mark K Ferguson; Francis C Nichols; K Robert Shen; Dennis A Wigle; Stephen D Cassivi
Journal:  Eur J Cardiothorac Surg       Date:  2015-02-26       Impact factor: 4.191

6.  Fluid administration and morbidity in transhiatal esophagectomy.

Authors:  Oliver S Eng; Renee L Arlow; Dirk Moore; Chunxia Chen; John E Langenfeld; David A August; Darren R Carpizo
Journal:  J Surg Res       Date:  2015-07-16       Impact factor: 2.192

Review 7.  Effects of neutrophil elastase inhibitor in patients undergoing esophagectomy: a systematic review and meta-analysis.

Authors:  Zhi-Qiang Wang; Long-Qi Chen; Yong Yuan; Wen-Ping Wang; Zhong-Xi Niu; Yu-Shang Yang; Jie Cai
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

8.  Esophagectomy--it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer.

Authors:  Donald E Low; Sonia Kunz; Drew Schembre; Henry Otero; Tom Malpass; Alex Hsi; Guobin Song; Richard Hinke; Richard A Kozarek
Journal:  J Gastrointest Surg       Date:  2007-08-31       Impact factor: 3.452

9.  Esophagectomy without mortality: what can surgeons do?

Authors:  Simon Law
Journal:  J Gastrointest Surg       Date:  2009-09-23       Impact factor: 3.452

10.  Transcervical gastric tube drainage facilitates patient mobility and reduces the risk of pulmonary complications after esophagectomy.

Authors:  Matthew J Schuchert; Brian L Pettiford; Joshua P Landreneau; Jonathon Waxman; Arman Kilic; Ricardo S Santos; Michael S Kent; Amgad El-Sherif; Ghulam Abbas; James D Luketich; Rodney J Landreneau
Journal:  J Gastrointest Surg       Date:  2008-06-17       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.